(Reuters) – Moderna Inc said on Friday it has signed an agreement with the U.S. government to supply 66 million doses of its bivalent booster vaccine that targets the Omicron variants of the coronavirus.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)
